News About: Pharm. Industry


70 Korean pharmas including Yuhan Corporation participate in ‘CPhI Worldwide 2018’

About 70 Korean pharmaceutical companies will participated in the world’s largest pharmaceutical conference held in Madrid, Spain on the coming 10th ‘CPhI Worldwide 2018’ and start to pioneer new exporting markets. T...

Daewoong finishes resubmitting documents for Nabota to FDA

Daewoong Pharmaceutical’s botulinum toxin ‘Nabota’ has taken the last step to enter the U.S. market. Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced on the 2nd that they turned in revised documents to the U.S. F...

Samsung Biologics acquires drug product manufacturing approval from U.S. FDA

Samsung Biologics(CEO Tae-Han Kim) announced on the 25th that they acquired manufacturing approval of its first finished drug product from the Food and Drug Administration, a federal agency of the United States Depart...

GC Pharm cruising to commercialize flu vaccine for the elderly

GC Pharm has gotten a step closer to commercializing influenza vaccines that are more effective with the elderly. GC Pharm(CEO Eun-Cheol Huh) announced on the 26th that they acquired approval of Phase II clinical tri...

Daewoong Pharmaceutical extends business in Vietnam in cooperation with Top 2 Vietnamese pharma ‘Traphaco’

Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced Branch Manager Dong-Hyu kim and an employee at a Vietnamese branch of Daewoong Pharmaceutical were appointed as member of board of directors and board of supervisor...

Pharma industry’s concern on MFDS’s investigation on Indian ingredients

Pharmaceutical companies have been extremely worried because the Chinese Valsartan ingredient incident has not been finalized by ‘product recall,’ but led to extensive investigation. According to the pharmaceutical i...

GOODTCELLS succeeds in attracting KRW 5 billion from Yuhan Corporation

GOODTCELLS, a biopharmaceutical venture specializing in immune disorder therapies, announced on the 23rd that the company succeeded in attracting a KRW 5 billion investment from Yuhan Corporation(CEO Jung-Hee Lee). Y...

Samyang Biopharmaceuticals working on opening a branch in world’s biopharmaceutical center Boston

Samyang Biopharmaceuticals will open a new branch in Boston, USA.  According to the company, Samyang Biopharmaceuticals is planning to open a branch in Boston this August; later, it will discover new drug and biologi...

Handok officially launches hangover relief ‘READY-Q’ in China

Handok(Chairman Young-Jin Kim) officially launches hangover relief ‘READY-Q’ in China.  Handok announced they completed shipping a large amount of products, 120 thousand ‘READY-Q Drink’ products and 77 thousand ‘READ...

A series of gene therapies expected to be commercialized with 65 clinical trials

It seems a series of products will be commercialized as the Ministry of Food and Drug Safety(MFDS) approved 65 cases of clinical trials for gene therapy development.  The MFDS approved Kolon Life Science’s ‘Invossa K...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.